Tuesday, June 30, 2026

Kakao Bank Hits New Milestones with 26% Profit Surge and 2 Million New Users

Kakao Bank's stock rises after reporting record profits and strong customer growth, with 24.88 million customers and increased engagement.

Korea Drug Development Fund Shifts Focus Toward Global Capital, Collaboration, and Commercialization

KDDF aims to enhance its role as a connection platform to expand global bio investment and collaboration.

Kia and Motability Launch Wheelchair-Accessible Electric Van in Push for Inclusive Transit

Kia introduces the wheelchair-accessible PV5 WAV in the UK, enhancing mobility for individuals with disabilities through innovative design.

Tag: ST Pharm

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm showcased its CDMO capabilities at TIDES USA and ASGCT 2026, focusing on nucleic acid therapeutics and strategic partnerships.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.